Artificial Saliva Breakthrough for Cancer Survivors

A healthcare professional in a lab preparing vaccine vials

Sugarcane protein turns artificial saliva into a tooth-saving shield for cancer patients stripped of natural protection by radiation.

Story Highlights

CANECPI-5 protein from sugarcane binds to enamel, blocking acids from food, drinks, bacteria, and stomach reflux.
Targets head and neck cancer patients suffering xerostomia after radiotherapy destroys salivary glands.
First product using acquired pellicle concept to reform protective tooth layer; outperforms prior artificial salivas.
Boosts power with fluoride and xylitol; tested in mouthwash, gel, and film formats.
In vitro success paves way for clinical trials, potential market product amid rising cancer treatments.

Radiotherapy’s Hidden Dental Devastation

Radiotherapy for head and neck cancer destroys salivary glands at FOB-USP patients’ sites. Patients lose saliva production essential for bacterial control and acid neutralization. Xerostomia follows, triggering rampant cavities from unchecked oral acids. Professor Marília Afonso Rabelo Buzalaf’s team at Bauru School of Dentistry, University of São Paulo, identified this gap. No prior product specifically countered post-radiation enamel erosion until CANECPI-5 emerged.

Cancer survivors face aggressive decay because dry mouths invite bacterial overgrowth. Stomach acids from reflux exacerbate damage without saliva’s buffer. This innovation shifts focus from mere moisture replacement to enamel fortification. Brazilian researchers extracted CANECPI-5 from sugarcane, lab-modified it for dental binding. FAPESP funding supported the thematic project on pellicle modulation.

CANECPI-5 Protein Mechanism Exposed

CANECPI-5 binds directly to tooth enamel, forming a resilient shield. Dr. Silva’s team proved it resists acids from bacterial metabolism, sodas, juices, and gastric reflux. In vitro tests on irradiated bovine enamel used cancer patient biofilms. The protein reforms acquired pellicle, the natural thin layer saliva builds on teeth. This first-of-its-kind approach surpasses symptom-only artificial salivas.

Researchers validated multiple formats: mouthwash spray, gel, orodispersible film. CANECPI-5 alone cuts bacterial activity; combinations amplify results.

Synergistic Power with Proven Allies

Fluoride and xylitol supercharge CANECPI-5. Tests showed the trio slashed demineralization and biofilm growth far beyond solo use. Demineralization leaches calcium and phosphate, priming cavities. Journal of Dentistry published these in vitro antimicrobial and anticaries effects. Head and neck patients gain targeted defense against their unique vulnerabilities.

Professor Buzalaf stresses temporary or permanent use based on gland recovery. Some regain saliva; radiation often causes irreversible loss. This formulation eases dry mouth sores while shielding teeth. Peer-reviewed data builds credibility for oncologists and dentists.

Future fusions with statherin target stomach acids stronger. Periodontal disease applications loom. Limited human trials noted; in vitro strength demands clinical proof. Scalability and costs remain pending, yet promise reduces restorative dental burdens on survivors.